IndraLab

Statements


Anthracycline decreases the amount of USP22. 1 / 1
| 1

reach
"Recently, Pirarubicin (4’-O-tetrahydropyranyl doxorubicin, THP), an anthracycline (analogue of another chemotherapeutic agent known as doxorubicin), has been shown to inhibit USP22 expression in a condition-specific manner ."